ArticleLeukemia & lymphoma2019

PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

Paulina Podszywalow-Bartnicka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.